Ryan-Poirier K, Suzuki Y, Bean W J, Kobasa D, Takada A, Ito T, Kawaoka Y
Department of a Virology and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Virus Res. 1998 Aug;56(2):169-76. doi: 10.1016/s0168-1702(98)00067-7.
Influenza A viruses of the H3 subtype caused the 1968 Hong Kong pandemic, the hemagglutinin (HA) gene being introduced into humans following a reassortment event with an avian virus. Receptor specificity and serum inhibitor sensitivity of the HA of influenza A viruses are linked to the host species. Human H3 viruses preferentially recognize N-acetyl sialic acid linked to galactose by alpha2,6 linkages (Neu5Acalpha2,6Gal) and are sensitive to serum inhibitors, whereas avian and equine viruses preferentially recognize Neu5Acalpha2,3Gal linkages and are resistant to serum inhibitors. We have examined the receptor specificity and serum inhibitor sensitivity of H3 human influenza A viruses from the time they were introduced into the human population to gain insight into the mechanism of viral molecular evolution and host tropism. All of the viruses were sensitive to neutralization and hemagglutination inhibition by horse serum. Early H3 viruses were resistant to pig and rabbit serum inhibitors. Viruses isolated after 1977 were uniformly sensitive to inhibition by pig and rabbit sera. The recognition of Neu5Acalpha2,3Gal or Neu5Acalpha2,6Gal linkages was not correlated with the serum sensitivity. These data showed that the receptor specificity of HA, measured as inhibitor sensitivity, has changed during replication in humans since its introduction from an avian virus.
H3亚型甲型流感病毒引发了1968年香港大流行,其血凝素(HA)基因是在与一种禽流感病毒发生重配事件后引入人类的。甲型流感病毒HA的受体特异性和血清抑制剂敏感性与宿主物种相关。人类H3病毒优先识别通过α2,6键与半乳糖相连的N-乙酰神经氨酸(Neu5Acalpha2,6Gal),并且对血清抑制剂敏感,而禽流感病毒和马流感病毒优先识别Neu5Acalpha2,3Gal键,并且对血清抑制剂具有抗性。我们研究了H3亚型人类甲型流感病毒自引入人类群体以来的受体特异性和血清抑制剂敏感性,以深入了解病毒分子进化和宿主嗜性的机制。所有病毒都对马血清的中和作用和血凝抑制作用敏感。早期的H3病毒对猪和兔血清抑制剂具有抗性。1977年之后分离出的病毒对猪和兔血清的抑制作用均敏感。对Neu5Acalpha2,3Gal或Neu5Acalpha2,6Gal键的识别与血清敏感性无关。这些数据表明,自从禽流感病毒引入以来,以抑制剂敏感性衡量的HA受体特异性在人类复制过程中发生了变化。